diabetes

Novel strategy for oral peptide delivery in incretin-based diabetes treatment
Yining Xu, Matthias Van Hul, Francesco Suriano, Véronique Préat, Patrice D Cani, Ana Beloqui

Gut Aug 2019, gutjnl-2019-319146; DOI: 10.1136/gutjnl-2019-319146
Epidemiology of chronic liver diseases in the USA in the past three decades
Zobair M Younossi, Maria Stepanova, Youssef Younossi, Pegah Golabi, Alita Mishra, Nila Rafiq, Linda Henry

Gut Jul 2019, gutjnl-2019-318813; DOI: 10.1136/gutjnl-2019-318813
PTH-003 Endobarrier®: a safe and effective novel treatment for obesity and type 2 diabetes?
A Mohanaruban, N Patel, H Ashrafian, K Stoenchev, C Le Roux, N Penney, J Kelly, J Byrne, J Hopkins, J Mason, J Teare

Gut Jul 2017, 66 (Suppl 2) A205; DOI: 10.1136/gutjnl-2017-314472.400
PWE-090 The liver as the homeostatic alarm: abnormal liver function tests precede the onset of diabetes mellitusby more than two years
MB Protty, HN Haboubi, F Yousuf, A Yeoman, S Jenkins, M Czajkowski

Gut Jul 2017, 66 (Suppl 2) A172; DOI: 10.1136/gutjnl-2017-314472.336
OC-001 Efficacy, safety and tolerability outcomes of endoscopic proximal intestinal exclusion using endobarrier, 12 and 18 month data for the uk’s first nhs endobarrier service for diabesity
M Anderson, PSen Gupta, M Yadagiri, S Irwin, W Burbridge, N Taylor, R Allden, M Wilson, H Gandhi, J Bleasdale, R Ryder, E Fogden

Gut Jul 2017, 66 (Suppl 2) A1; DOI: 10.1136/gutjnl-2017-314472.1
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
Hsiao-Ping Chen, Jeng-Jer Shieh, Chia-Che Chang, Tzu-Ting Chen, Jaw-Town Lin, Ming-Shiang Wu, Jeng-Horng Lin, Chun-Ying Wu

Gut Apr 2013, 62 (4) 606-615; DOI: 10.1136/gutjnl-2011-301708

Log in using your username and password

Main menu

Log in using your username and password

You are here

diabetes